The effects of rhBMP-2 around endosseous implants with and without membranes in the canine model

Journal of Periodontology

Volumn 77, Issue 7, 2006, Pages 1184-1193

  Jones, Archie A ^a   Buser, Daniel ^b   Schenk, Robert ^b   Wozney, John ^c   Cochran, David L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c PFIZER INC   (United States)

Author keywords

BMP; Bone morhogenetic protein; Bone regeneration; Defects; Dental implants; Membranes

Indexed keywords

COLLAGEN; POLITEF; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABLE IMPLANT; BONE DEFECT; BONE RADIOGRAPHY; BONE REGENERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; MALE; NONHUMAN; OSSIFICATION; POLITEF IMPLANT; PREMOLAR TOOTH; TOOTH IMPLANTATION; WOUND HEALING; ANIMAL; ARTIFICIAL MEMBRANE; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; IMPLANT; METHODOLOGY; NONPARAMETRIC TEST; PERIODONTICS; PERIODONTITIS;

ABSORBABLE IMPLANTS; ANIMALS; BONE MORPHOGENETIC PROTEINS; COLLAGEN; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DOGS; DRUG CARRIERS; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; IMPLANTS, EXPERIMENTAL; LACTIC ACID; MALE; MEMBRANES, ARTIFICIAL; MODELS, ANIMAL; OSSEOINTEGRATION; PERIODONTITIS; POLYGLYCOLIC ACID; POLYMERS; POLYTETRAFLUOROETHYLENE; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33748565007     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050337     Document Type: Article

References (21)

1. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 1991;62:710-716.
2. Becker W, Lynch SE, Lekholm U, et al. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like Prowth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992;63: 929-940.
3. Rutherford RB, Sampath TK, Rueger DC, Taylor TD. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992;7:297-301.
4. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UM. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997;12: 604-610.
5. Sigurdsson TJ, Fu E, Tatakis DM, Rohrer MD, Wikesjö UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-374.
6. Jovanovic SA, Hunt DR, Bernard GW, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14:793-803.
7. Sorensen RG, Wikesjö UM, Kinoshita A, Wozney JM. Periodontal repair in dogs: Evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2. J Clin Periodontol 2004;31:796-804.
8. Cochran DL, Nummikoski PV, Jones AA, Makins SR, Turek TJ, Buser D. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 1997;12:739-748.
9. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-150.
10. Sigurdsson TJ, Nygaard L, Tatakis DM, et al. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
11. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71:1241-1257.
12. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:124-139.
13. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11-25.
14. Schenk RK, Olah AJ, Hermann W. Preparation of calcified tissues for light microscopy. In: Dickson GR, ed. Methods of Calcified Tissue Preparation, vol. 1. Amsterdam: Elsevier; 1984:1-56.
15. Schenk RK, Olah AJ. Histomorphometrie. In: Kuhlencordt S, Bartelheimer H, eds. Handbook of Inner Medicine VI/IA (in German). Berlin: Springer-Verlag; 1980: 437-494.
16. Cochran D. Implant therapy I. Ann Periodontol 1996; 1:707-791.
17. Buring K, Urist MR. Transfilter bone induction. Clin Orthop 1967;54:235-242.
18. Wikesjö UM, Sorensen RG, Wozney JM. Augmentation of alveolar bone and dental implant osseointegration: Clinical implications of studies with rhBMP-2. J Bone Joint Surg Am 2001;83:S136-S145.
19. Bessho K, Kusumoto K, Fujimura K, et al. Comparison of recombinant and purified human bone morphogenetic protein. Br J Oral Maxillofac Surg 1999; 37:2-5.
20. Okubo Y, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Lizuka T. Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2. Clin Oral Implants Res 2002;13:80-85.
21. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjö UM. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995;66:131-138.